SHERIDAN, WYOMING – November 09, 2024-Company Maintains Positive Outlook for the Remainder of the Fiscal Year
FUJIFILM Holdings Corporation today announced strong financial results for the first half of the fiscal year ending March 31, 2025. The company reported a 9.1% year-over-year increase in revenue, reaching JPY1,514.7 billion. This growth was primarily fueled by strong sales in the Electronics and Imaging businesses, along with favorable foreign exchange rates.
Operating income also demonstrated a healthy increase of 8.0% year-over-year, reaching JPY135.6 billion. The company attributed this growth to the increase in revenue and the positive impact of exchange rates.
Despite a slight decrease in net income attributable to FUJIFILM Holdings, which was down 2.9% year-over-year to JPY110.3 billion, the company remains optimistic about its future prospects.
"We have continued strong performance in the Electronics and Imaging segments, resulting in unprecedented sales and operating profit in the first half of fiscal year 2024," said Teiichi Goto, president and chief executive officer, representative director, FUJIFILM Holdings Corporation.
In light of the strong first-half performance, Fujifilm has maintained its full-year consolidated forecast for the fiscal year ending March 31, 2025. The company expects revenue to reach JPY3,150.0 billion, operating income to reach JPY315.0 billion, and net income attributable to FUJIFILM Holdings to reach JPY250.0 billion. If achieved, these figures would represent record highs for the company.
Business Segment Highlights
Healthcare:
Revenue increased 0.6% year-over-year to JPY242.9 billion, driven by strong performances in the Medical Systems and Life Science Solutions businesses.
Medical Systems experienced growth due to robust sales of endoscopes and in vitro diagnostic (IVD) products.
Life Science Solutions saw increased revenue due to a rebound in order volume for culture media, as customer inventory adjustments related to the coronavirus pandemic eased.
Electronics:
Revenue increased 31.4% year-over-year to JPY108.7 billion, and operating income increased 94.2% year-over-year to JPY19.5 billion. Electronic Materials revenue increased 46.7% year-over-year, driven by market recovery in semiconductor materials and contributions from a recently acquired semiconductor process chemicals business.
Advanced Functional Materials revenue increased 14.9% year-over-year, fueled by favorable orders for antireflection materials for organic light-emitting diodes (OLEDs).
Imaging:
Revenue increased 11.0% year-over-year to JPY126.5 billion, and operating income increased 29.2% year-over-year to JPY33.7 billion. Consumer Imaging revenue was driven by continued strong sales of the "instax" instant photo systems.
Professional Imaging revenue increased due to strong sales of the latest GFX and X Series digital cameras released in June 2024, as well as continued demand for previously released models.
Investing in Future Growth
Fujifilm is committed to investing in strategic growth areas such as semiconductor materials and bio-contract development and manufacturing organization (CDMO). These investments demonstrate the company's confidence in its ability to expand its business and achieve continued success.
"We are maintaining our performance forecast to achieve record-high sales and profitability for the fiscal year ending March 2025," said Goto. "We are actively investing in facilities in growth areas such as Semiconductor Materials and Bio CDMO, demonstrating our confidence in expanding our business."
About Fujifilm
FUJIFILM Holdings Corporation, headquartered in Tokyo, Japan, is a leading global company operating in a wide range of business segments, including healthcare, electronics, imaging, and business innovation. The company is dedicated to leveraging its expertise and innovative technologies to develop products and services that contribute to improving the quality of life around the world.